Ganga Pharmaceuticals (BOM:539680) YoY EBITDA Growth : -48.61% (As of Mar. 2025)

View and export this data going back to 2016. Start your Free Trial

What is Ganga Pharmaceuticals YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Ganga Pharmaceuticals's YoY EBITDA Growth for the quarter that ended in Mar. 2025 was -48.61%.

Ganga Pharmaceuticals's EBITDA per Share for the six months ended in Mar. 2025 was ₹0.17.

Ganga Pharmaceuticals YoY EBITDA Growth Historical Data

The historical data trend for Ganga Pharmaceuticals's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ganga Pharmaceuticals YoY EBITDA Growth Chart

Ganga Pharmaceuticals Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

YoY EBITDA Growth

Get a 7-Day Free Trial

-48.77

9.62

-99.86

70,100.00

-30.77

Ganga Pharmaceuticals Semi-Annual Data
	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24	Mar25
YoY EBITDA Growth	Get a 7-Day Free Trial															-48.56	-29.27	29.20	7.76	-48.61

Ganga Pharmaceuticals YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Ganga Pharmaceuticals's YoY EBITDA Growth for the fiscal year that ended in Mar. 2025 is calculated as:

	YoY EBITDA Growth (A: Mar. 2025 )
=	(EBITDA per Share (A: Mar. 2025 )	-	EBITDA per Share (A: Mar. 2024 ))	/	\| EBITDA per Share (A: Mar. 2024 ) \|
=	(0.486	-	0.702)	/	\| 0.702 \|
=	-30.77 %

Ganga Pharmaceuticals's YoY EBITDA Growth for the quarter that ended in Mar. 2025 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2025 )
=	(EBITDA per Share (Q: Mar. 2025 )	-	EBITDA per Share (Q: Mar. 2024 ))	/	\| EBITDA per Share (Q: Mar. 2024 )) \|
=	(0.166	-	0.323)	/	\| 0.323 \|
=	-48.61 %

Ganga Pharmaceuticals YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Ganga Pharmaceuticals's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Ganga Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ganga Pharmaceuticals Ltd (BOM:539680) » Definitions » YoY EBITDA Growth

Traded in Other Exchanges

N/A

Address

Dhanvantri Marg, Gangatat, Gopcharpada, Near Digi 1 Electronic Showroom, Virar (East), Palghar, MH, IND, 401305

Website

https://www.ayurvedganga.com

Ganga Pharmaceuticals Ltd is an India based producer of ayurvedic medicines. It is engaged in the business of manufacturing and trading in ayurvedic pharmaceuticals and allied products. The company is also involved in the marketing and distribution of bulk ayurvedic medicines. The firm offers ayurvedic medicines for acidity, anti-dandruff, anti-oxidants, dental care, diarrhea, iron tonic, liver disorder, weight management, kidney stone, joint pains, liver disorder and others.

Ganga Pharmaceuticals Headlines

No Headlines